CAR-T 细胞治疗 在华费用

各家来源报告的「CAR-T 细胞治疗」在华费用约 $65,000 至 $181,690(美元) 共 8 条有来源记录(2024、2025、2026)。来源不同,我们从不取平均。

全部条目

AmountCity / hospitalIncludesPatient typeYearSourceStatus
$150,000 to $180,000 -细胞采集与制备, 住院, 所报道的治疗过程international-dept2026AFP / Free Malaysia Today有报道
最后核验
$65,000 -CAR-T治疗, 所报道的患者全流程费用international-dept2026AFP / Free Malaysia Today有报道
最后核验
¥999,000 to ¥1,290,000 about $140,704 to $181,690-中国已获批CAR-T产品的每次输注挂牌价(仅药品), 不含操作、住院及机构费用, 为全国挂牌价,非特定医院价格unknown2024International Journal of Health Policy and Management (via PMC)有报道
最后核验
¥1,200,000 about $169,014-阿基仑赛注射液(奕凯达)国内挂牌价,即中国首个获批的CAR-T产品,每次输注, 仅药品价格,住院和监测费用未公布, 据2024年报道,如未达到完全缓解,厂家按疗效付费计划最高退还60万元人民币unknown2024Securities Times (citing National Business Daily)有报道
最后核验
$150,000 to $180,000 -单次CAR-T细胞输注(相当于美国同类产品)unknown2026The Straits Times / Bloomberg有报道
最后核验
$65,000 shanghai临床试验治疗、住院护理及机票费用international-dept2025The Straits Times / Bloomberg有报道
最后核验
¥990,000 about $139,437shanghai实体瘤单次CAR-T细胞注射unknown2026The Insight Asia / Caijing有报道
最后核验
$65,000 -治疗, 患者住院住宿, 双人餐食, 机场接送unknown2025Facebook group: MULTIPLE MYELOMA SUPPORT GROUP自述
最后核验

需要注意

信息来源

  1. China lures foreign patients with cutting-edge, cheap medical care
    AFP / Free Malaysia Today · news · accessed 2026-10-26
    “2026-10-26”
  2. China lures foreign patients with cutting-edge, cheap medical care
    AFP / Free Malaysia Today · news · accessed 2026-10-26
    “New Zealand patient Stuart Lye's total cost was reported around USD 65,000.”
  3. A New Outcomes-Based Payment Plan From a Chinese Company to Improve Patient Affordability of CAR-T Product
    International Journal of Health Policy and Management (via PMC) · news · accessed 2026-10-26
    “The current list pricing ranges between 0.999 million and 1.29 million RMB per infusion, far more expensive than standard-of-care therapies.”
  4. Gilead's Kite exits China cell therapy JV with Fosun Pharma
    Fierce Pharma · news · accessed 2026-10-26
    “The list price for Yescarta in China is 1.2 million yuan (about $170,000).”
  5. 价格高达百万元的CAR-T产品如何打通“最后一公里”?
    Securities Times (citing National Business Daily) · news · accessed 2026-10-26
    “奕凯达是中国首款获批的CAR-T细胞治疗产品,国内定价为120万元一针。”
  6. China Focus: More health insurance coverage for cancer patients in China
    Xinhua · news · accessed 2026-10-26
    “it was once priced at over 1 million yuan per infusion.”
  7. China lures foreign patients with cutting-edge, cheap medical care (Bloomberg)
    The Straits Times / Bloomberg · news · accessed 2026-10-26
  8. China lures foreign patients with cutting-edge, cheap medical care (Bloomberg)
    The Straits Times / Bloomberg · news · accessed 2026-10-26
  9. A $137,000 cancer shot brings foreign patients to China (from Caijing)
    The Insight Asia / Caijing · news · accessed 2026-10-26
  10. BCMA CAR-T treatment option in Kunming, China (public post)
    Facebook group: MULTIPLE MYELOMA SUPPORT GROUP · self-reported · accessed 2026-10-26

本站仅提供信息,不构成医疗建议、诊断或治疗推荐。请咨询你的医生。紧急情况请立即拨打当地急救电话。